FILTER

Refine your search with the following facets to narrow down your results.

11 Current news of Biotechnology Application Centre

GE Healthcare and BAC collaborate to launch new bioprocess affinity resin

21-Mar-2012 - GE Healthcare and BAC BV announced that, following a successful collaboration between the two companies, GE Healthcare Life Sciences has added a new affinity resin to its portfolio of technologies for the purification of antibody-based fragments. GE Healthcare’s new resin, LambdaFabSelect, is a ...

affinity resins antibodies GE Healthcare +1

BAC BV collaborates with Life Technologies to provide new HPLC affinity columns

22-Jun-2011 - BAC BV has announced a strategic collaboration with Life Technologies to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns. The collaboration will create a range of ready-to-use HPLC columns ...

chromatography hplc/uhplc Life Technologies +1

BioSystem Development and BAC BV collaborate to bring purification ligands to high throughput biotherapeutic process development

08-Nov-2010 - BioSystem Development and BAC BV announced a collaboration to bring state-of-the-art high affinity ligands to the AssayMAP high-throughput micro-chromatography platform. This collaboration marks an essential objective toward growing a family of high-throughput tools for micro-scale purification ...

antibodies antibody fragments bioprocess +5

BAC and Octapharma extend collaboration for G-CSF custom ligand for commercial scale manufacture

18-Aug-2010 - BAC BV announced that it has entered into a licence agreement with Octapharma. Under the terms of the license, Octapharma can use BAC’s G-CSF CaptureSelect® custom affinity ligand for the purification of recombinant human granulocyte-colony stimulating factor (G-CSF) from human (HEK293F) cell ...

affinity chromatography antigens bone marrow +10

BAC Extends Partnership with GE Healthcare to Launch Alpha-1 Antitrypsin Select

19-Feb-2010 - BAC BV has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare’s range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood ...

affinity chromatography affinity resins Baxter +10

BAC and Octapharma Extend Recombinant Factor IX Collaboration for Clinical and Commercial Scale Production

04-Nov-2009 - BAC BV announced that it has entered into a licence agreement with Octapharma to use BAC’s anti-Factor IX CaptureSelect® affinity ligand in the large scale purification of recombinant Factor IX (FIX). Octapharma produces FIX for the treatment of bleeding in Haemophilia B. The licence agreement ...

antigens cell cultures hemophilia B +2

BAC and LFB Biotechnologies to Develop Custom Ligand for Purifying Recombinant Factor VIIa

30-May-2008 - BAC BV, the Bio Affinity Company, announced that it has entered into a collaboration with LFB Biotechnologies, a wholly owned subsidiary of LFB S.A., a biopharmaceutical company working in the highly specialized field of plasma-derived medicinal and biotech products. Working with LFB, BAC will ...

Expression ligands monoclonal antibodies +4

BAC signs license agreement with Hematech

26-Mar-2008 - BAC BV announced that it has entered into a license and supply agreement with Hematech, Inc., a subsidiary of Kirin Pharma that specialises in the production of human antibodies in transgenic cows. The license covers the use of a custom designed bovine IgG scavenging ligand which BAC had ...

GE Healthcare human antibodies license agreements +1

BAC and Octapharma to develop custom ligand for recombinant plasma protein

18-Mar-2008 - BAC BV announced that it has entered into a collaboration with Octapharma AG. The objective of the collaboration is to discover and develop a custom CaptureSelect(r) ligand for the purification of a recombinant Factor IX product, developed by Octapharma for the prophylaxis and treatment of ...

cell lines hemophilia B ligands +1

BAC appoints Dr Andrew Carr as Chairman of Supervisory Board

30-Jan-2008 - BAC BV, the Bio Affinity Company, announced the appointment of Dr Andrew Carr as Chairman to its Supervisory Board. Dr Carr brings a wealth of experience in the biotech industry to the role. As CEO of Amersham Biosciences and a Director of Amersham plc, Dr Carr played a key role in growing the ...

Amersham GE Healthcare Life Science